Oesophageal Reflux Disease Diagnosis, Pathophysiology and Treatment with Special Reference to the Role of Sucralfate

References

• Tibbling L. Epidemiology of Gastro-oesophageal Reflux Disease. Function and Disease of the Oesophagus, N Sandberg, A Walan, Stockholm 1984; 14–15
   Google Scholar
• Nebel O T, Forties M F, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am. J. Dig. Dis. 1976; 21: 953–956
   PubMedGoogle Scholar
• Monnier P H, Savary M. Contribution of Endoscopy to Gastro-oesophageal Reflux Disease. Function and Disease of the Oesophagus, N Sandberg, A Walan, Stockholm 1984; 26–44
   Google Scholar
• Reed PI: Oesophageal reflux. Practitioner 1980; 224: 357–363
   PubMedGoogle Scholar
• Edwards D AW. The anti-reflux mechanism, its disorders and their consequences. Clinics in Gastroenterology Vol. 11:3 Motility and its Disturbances. W B Saunders Co., London 1982; 479–486
   Google Scholar
• Corazziari E, Bontempo I, Anzini F, Torsoli A. Motor activity of the distal oesophagus and gastro-oesophageal reflux. Gut. 1984; 24: 7–13
   Google Scholar
• Elsborg Stubgaard L. M, Beck B, Malchow-Moeller A. A portable System for recording Oesophageal pH in Reflux Oesophagitis. Scand. J. Gastroenterol. 1983; 18: 14, suppl. 86
   Google Scholar
• Behar J, Sheahan D G, Bianci P, Spiro H M, Storer EH. Medical and surgical management of reflux esophagitis. N. Eng. J. Med. 1975; 293: 263–268
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE. Treatment of reflux oesophagitis. Scand. J. Gastroenterol. 1982; 17: 106–118, suppl. 79
   Google Scholar
• Bright-Asare P, El-Bassoussi M. Cimetidine, metoclopramide or placebo in the treatment of symptomatic gastro-oesophageal reflux. J. Cl in. Gastroenterol. 1980; 2: 149–155
   PubMed Web of Science ®Google Scholar
• Behar J, Brand D. L, Brown FC, et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux. A double blind controlled trial. Gastroenterology 1978; 74: 441–8
   PubMed Web of Science ®Google Scholar
• Powell-Jackson P, Barkley H, Northfield TC. Effect of cimetidine in symptomatic gastroesophageal reflux. Lancet 1978; 2: 1068–9
   PubMed Web of Science ®Google Scholar
• Wesdorp Bartelsman E. J, Pape K, Dekker W, Tytgat GN. Oral cimetidine in reflux esophagitis: A double blind controlled trial. Gastroenterology 1978; 74: 821–4
   PubMedGoogle Scholar
• Brown P. Cimetidine in the treatment of reflux oesophagitis. Med. J. Aust. 1979; 2: 96–7
   PubMed Web of Science ®Google Scholar
• Ferguson R, Dronfield M W, Atkinson M. Cimetidine treatment of reflux oesophagitis with peptic, stricture. Br. Mrcl. J. 1979; 2: 472–4
   PubMed Web of Science ®Google Scholar
• Lepsien G, Sonnenberg A, Berges W, Welier K B, Wienbeek M., Siewert J R, Blum AL. Die Behandlung clrr Reflux Oesophagitis mit Cimetidin. Dtsch. Med. Wochenschr. 1979; 104: 901–6
   PubMed Web of Science ®Google Scholar
• Petrokuvi R J, Jeffries GH. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Gastroenterology 1979; 77: 691–5
   PubMed Web of Science ®Google Scholar
• Bradby G VH, Hawkins C F, Hoare AM. Cimetidine (Tagamet) in oesophageal reflux. Clinical Trials Journal 1980; 17: 81–3
   Google Scholar
• Bright-Asare P, El-Bassoussi M. Cimetidine, metoclopramide. or placebo in the treatment of symptomatic gastroesophageal reflux. J. Clin. Gastroenterol. 1980; 2: 149–156
   PubMed Web of Science ®Google Scholar
• Festen H PM, Driessen W MM, Lamers C BH, Van Tongeren JHM. Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8–week double-blind study and of subsequent long-term maintenance treatment. Neth. J. Med. 1980; 23: 237–40
   PubMed Web of Science ®Google Scholar
• Fiasse R, Hanin C, Lepot A, Descamps C, Lamy F, Dive C. Controlled trial of cimetidine in reflux oesophagitis. Dig. Dis. Sci. 1980; 25: 750–5
   PubMed Web of Science ®Google Scholar
• Greaney M G, Lrvin TT. Cimetidine for the treatment of symptomatic gastro-oesophageal reflux. Br. J. Clin. Pract. 1981; 35: 21–4
   PubMedGoogle Scholar
• Berstad A. Overview of ranitidine in reflux oesophagitis: its effect on symptoms, endoscopic appearance and histology. The clinical use of ranitidine. Medicine publishing Foundation Series 5, JJ Misiewicz, KG Wormsley. Oxford 1982; 295–302
   Google Scholar
• Sherbanuik R, Wensel R, Troutman A, Grace M, Kirdeikidis P, Jewell L, Pare P, Levesque D, Farley A, Archambault A, Thompson A BR. Ranitidine in short-term management of symptomatic gastro-oesophageal reflux. The clinical use of ranitidine. Medicine Publishing Foundation Series 5, J J Mesiewicz, KG Wormsley. Oxford 1982; 281–290
   Google Scholar
• Guslandi M, Testoni P A, Passarette S, Masci E, Comin U, Marchi R, Ronchi G, Tittbello A, Ranitidine VS. Metoclopramide in the Medical Treatment of Reflux Esophagitis. Hepatogastroenterology 1983; 30: 96–98
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE, Dekker W, Klinkenberg-Knol EC. Treatment of reflux oesophagitis with ranitidine. GUT 1983; 24: 921–924
   PubMed Web of Science ®Google Scholar
• Berges W, Sonneberg A, Wienbeck M. Sueralfat bei Refluxoesophagitis. Dtsch. Med. Wschr. 1981; 106: 853–854
   Web of Science ®Google Scholar
• Laitinen S, Stählberg M, Kairalouma M I, Kiviniemi H, Pääkkönen M, Lahtinen J, Poikolainen E, Aukee S. Sueralfate and alginate/antacids in reflux esophagitis. XII Int. Congr. Gastroent. LisbonPortugal 1984, Abstr. 1178
   Google Scholar
• Weiss W, Brunner H, Büttner G R, Gabor M, Miederer S, Mittelstaedt A, Olbermann M, Schwamberger K, Witzel L. Therapie der Refluxösophagitis mit Sucralfat. Dtsch. Med. Wschr. 1983; 108: 1706–1711
   PubMed Web of Science ®Google Scholar
• Silber W. A Randomised Double Blind Cross-over Trial of Lusanic (Sucralfate). Reflux Oesophagitis XII Int. Congr. Gastroent. LisbonPortugal 1984, Abstr. 1118
   Google Scholar
• Elsborg L, Beck B, Stubgaard M. Effect of sucralfate on gastro-oesophageal reflux in oesophagitis. Hepato-gastroenterol. 1985; 32: 181–184
   PubMedGoogle Scholar